NCT06211569 Study of the Prevalence of Endometriosis and Adenomyosis
| NCT ID | NCT06211569 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Elective Fertility Preservation |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2024-04-04 |
| Primary Completion | 2027-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2024-04-04 with a primary completion date of 2027-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Our study aims to assess the prevalence of adenomyosis and endometriosis in patients consulting for elective fertility preservation through the diagnosis of these pathologies by transvaginal pelvic ultrasound. Imaging data will be compared with clinical data (patient characteristics, clinical symptoms) as well as the assessment of anxiety, depression, and quality of life collected from the women.
Eligibility Criteria
Inclusion Criteria: * Woman aged between 29 and 37 * Consultant for non-medical fertility preservation in the Reproductive Medicine Unit Port Royal, Cochin * Informed and not opposed to this research * Affiliated to a social security scheme Exclusion Criteria: * Pregnant women * Refusing to take part in the study * Under court protection, curatorship or guardianship * Women with a known malformation of the genital tract
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06211569 clinical trial?
This trial is open to female participants only, aged 29 Years or older, up to 37 Years, studying Elective Fertility Preservation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06211569 currently recruiting?
Yes, NCT06211569 is actively recruiting participants. Contact the research team at mathilde.bourdon@aphp.fr for enrollment information.
Where is the NCT06211569 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT06211569 clinical trial?
NCT06211569 is sponsored by Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 400 participants.